- Home
- ONCY vs DOMH Comparison
ONCY vs DOMH Comparison
Compare ONCY & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- DOMH
- Stock Information
- Founded
- ONCY 1998
- DOMH 1967
- Country
- ONCY Canada
- DOMH United States
- Employees
- ONCY N/A
- DOMH N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- DOMH Health Care
- Exchange
- ONCY Nasdaq
- DOMH Nasdaq
- Market Cap
- ONCY 89.7M
- DOMH 74.7M
- IPO Year
- ONCY 1999
- DOMH N/A
- Fundamental
- Price
- ONCY $1.05
- DOMH $5.11
- Analyst Decision
- ONCY Strong Buy
- DOMH
- Analyst Count
- ONCY 4
- DOMH 0
- Target Price
- ONCY $4.33
- DOMH N/A
- AVG Volume (30 Days)
- ONCY 1.5M
- DOMH 205.3K
- Earning Date
- ONCY 08-08-2025
- DOMH 08-07-2025
- Dividend Yield
- ONCY N/A
- DOMH 6.26%
- EPS Growth
- ONCY N/A
- DOMH N/A
- EPS
- ONCY N/A
- DOMH N/A
- Revenue
- ONCY N/A
- DOMH $24,891,000.00
- Revenue This Year
- ONCY N/A
- DOMH N/A
- Revenue Next Year
- ONCY N/A
- DOMH N/A
- P/E Ratio
- ONCY N/A
- DOMH N/A
- Revenue Growth
- ONCY N/A
- DOMH 630.80
- 52 Week Low
- ONCY $0.33
- DOMH $0.83
- 52 Week High
- ONCY $1.53
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- ONCY 53.00
- DOMH 47.61
- Support Level
- ONCY $1.18
- DOMH $5.01
- Resistance Level
- ONCY $1.35
- DOMH $5.35
- Average True Range (ATR)
- ONCY 0.13
- DOMH 0.33
- MACD
- ONCY -0.03
- DOMH -0.03
- Stochastic Oscillator
- ONCY 14.29
- DOMH 34.51
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.